Sunmax Biotechnology Co Ltd (4728) — Cash Flow Reinvestment Rate
Sunmax Biotechnology Co Ltd (4728) has a Cash Flow Reinvestment Rate of 1.35x as of September 2025, reinvesting NT$217.44 Million (capex NT$17.44 Million plus investments NT$-200.00 Million) from operating cash flow of NT$160.84 Million. Check Sunmax Biotechnology Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sunmax Biotechnology Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Sunmax Biotechnology Co Ltd across 9 annual periods. Explore 4728 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Sunmax Biotechnology Co Ltd. For live market cap and broader valuation context, see Sunmax Biotechnology Co Ltd (4728) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | NT$53.71 Million | NT$397.37 Million | NT$36.61 Million | ▼ -9.3% |
| 2023 | 0.15x | NT$126.43 Million | NT$848.56 Million | NT$110.39 Million | ▼ -86.3% |
| 2022 | 1.09x | NT$372.50 Million | NT$342.97 Million | NT$152.03 Million | ▼ -10.5% |
| 2021 | 1.21x | NT$295.11 Million | NT$243.28 Million | NT$255.43 Million | ▲ +195.3% |
| 2020 | 0.41x | NT$158.97 Million | NT$386.97 Million | NT$130.10 Million | ▲ +2.5% |
| 2019 | 0.40x | NT$116.05 Million | NT$289.51 Million | NT$13.68 Million | ▼ -56.3% |
| 2018 | 0.92x | NT$92.50 Million | NT$100.83 Million | NT$4.72 Million | ▼ -72.0% |
| 2017 | 3.28x | NT$121.50 Million | NT$37.09 Million | NT$3.15 Million | ▲ +514.9% |
| 2016 | 0.53x | NT$8.83 Million | NT$16.58 Million | NT$4.73 Million | — |